Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ajax Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Ajax Therapeutics

Ajax Therapeutics

Ajax develops precise, best-in-class therapies for hematologic malignancies using advanced structural biology and computational chemistry.

HQ
New York City, NY, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Ajax Therapeutics, founded with a mission to revolutionize the treatment of hematologic malignancies, leverages advanced structural biology and computational chemistry to develop precise, best-in-class therapies. The company focuses on myeloproliferative neoplasms (MPNs) and aims to address significant unmet medical needs by creating targeted therapies that minimize interactions with non-target proteins, thereby enhancing efficacy and reducing side effects.

Notable figures associated with Ajax Therapeutics include experts in molecular genetics and structural biology, although specific names are not provided. The company has made significant strides in drug discovery and development, positioning itself as a leader in the field of hematologic cancer treatment. Its impact is marked by the potential to offer more effective and safer treatment options for patients suffering from MPNs and other hematologic malignancies.

Ajax Therapeutics - Similar Companies

Ajax Health logo

Ajax Health

ajaxhealth.com

Adcentrx Therapeutics logo

Adcentrx Therapeutics

adcentrx.com

Aether Therapeutics logo

Aether Therapeutics

Accent Therapeutics logo

Accent Therapeutics

accenttx.com

Athos Therapeutics logo

Athos Therapeutics

athostx.com

Akebia Therapeutics logo

Akebia Therapeutics

akebia.com

Nine Square Therapeutics logo

Nine Square Therapeutics

ninesquaretx.com

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Axonis Therapeutics logo

Axonis Therapeutics

Bluejay Therapeutics logo

Bluejay Therapeutics

bluejaytx.com

AimMax Therapeutics logo

AimMax Therapeutics

aimmaxrx.com

Window Therapeutics logo

Window Therapeutics

windowtx.com

Apexian Pharmaceuticals logo

Apexian Pharmaceuticals

apexianpharma.com

Nextrna Therapeutics logo

Nextrna Therapeutics

AsclepiX Therapeutics logo

AsclepiX Therapeutics

asclepix.com

Ajax Therapeutics - Quick Facts

Who are Ajax Therapeutics' competitors?

Companies similar to Ajax Therapeutics include Ajax Health, Adcentrx Therapeutics, Aether Therapeutics and Accent Therapeutics.

When was Ajax Therapeutics founded?

Ajax Therapeutics was founded in 2019.

Where is Ajax Therapeutics' headquarters located?

Ajax Therapeutics' headquarters is located in New York City, NY, US.

When was Ajax Therapeutics' last funding round?

Ajax Therapeutics' most recent funding round was for $40M (USD) in June 2021.

How much has Ajax Therapeutics raised to-date?

As of Jun 1, 2021, Ajax Therapeutics has raised a total of $40M (USD).

How many employees does Ajax Therapeutics have?

Ajax Therapeutics has 15 employees as of Feb 5, 2024.

Ajax Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified